Gefitinib (ZD1839, Iressa™) as palliative treatment in recurrent or metastatic head and neck cancer

To assess the level of activity and toxicity of gefitinib (ZD1839, Iressa™) in a population of patients with locally recurrent and/or metastatic head and neck cancer. Patients were recruited into an expanded access programme through the multidisciplinary head and neck clinics at the Royal Marsden an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kirby, A M, A'hern, R P, D'ambrosio, C, Tanay, M, Syrigos, K N, Rogers, S J, Box, C, Eccles, S A, Nutting, C M, Harrington, K J
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2006
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361202/
https://ncbi.nlm.nih.gov/pubmed/16495923
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602999
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados